Home / Products / Anabolic Injectables / TMT 400 10ML 150MG/ML TEST E 150MG/ML TREN E 100MG/ML MAST E

Anabolic Injectables

TMT 400 10ML 150MG/ML TEST E 150MG/ML TREN E 100MG/ML MAST E

(0 Review)

£39.00 £35.10

TMT 400 10ML

Quantity

Out of Stock

MKS : J-8521

Category : Anabolic Injectables

Tags : Trending Product

TMT 400

Testosterone Enanthate / Trenbolone Enanthate / Drostanolone Enanthate Injection

Packaging: 10 mL multidose vial
Strength: 150 mg/mL Testosterone Enanthate + 150 mg/mL Trenbolone Enanthate + 100 mg/mL Drostanolone Enanthate
Total concentration: 400 mg/mL

Generic name: A fixed-dose injectable blend of testosterone enanthate, trenbolone enanthate, and drostanolone (dromostanolone) enanthate.

Product Overview

TMT 400 is presented as a concentrated oil-based injectable androgen/anabolic steroid blend combining three esterified active components: testosterone enanthate, trenbolone enanthate, and drostanolone enanthate. As esterified compounds, these ingredients are intended to provide a more prolonged release profile than non-esterified parent hormones after injection.

Description

This formulation combines a testosterone ester with two additional anabolic-androgenic steroid esters in a single vial. In regulated drug references, testosterone enanthate is an established injectable androgen, while trenbolone is primarily associated with veterinary use and drostanolone has largely been discontinued from routine medicinal use in modern references. As a result, this fixed-dose combination should be treated as a non-standardized androgen blend, not as a routine approved therapeutic medicine.

Indications

Catalog note: There is no standard FDA-approved therapeutic indication for this exact three-drug combination. Testosterone enanthate is used in approved products for testosterone replacement therapy in adult males with confirmed deficiency or absence of endogenous testosterone. Any use of this blend should be determined only by a licensed clinician in accordance with local law, product registration status, and patient-specific risk assessment.

Dosage & Administration

Because this fixed-dose blend does not have standardized approved prescribing guidance, no evidence-based universal dosage can be recommended for a pharmacy reference entry. Administration should be performed only under licensed medical supervision, following the specific product label, sterile technique, and applicable regulatory requirements. Injectable androgen preparations should be visually inspected before use and should not be used if the solution is cloudy or contains visible particulate matter.

Mechanism of Action

The active components act through androgen receptor signaling. Testosterone and related anabolic-androgenic steroids influence gene transcription involved in male sexual development, maintenance of secondary sex characteristics, and anabolic effects on skeletal muscle. Testosterone enanthate is converted to testosterone after ester cleavage; testosterone can then exert androgenic effects directly or via metabolites such as dihydrotestosterone (DHT).

Precautions

Use with caution in patients with hypertension, polycythemia risk, thromboembolic risk, benign prostatic hyperplasia, possible prostate malignancy, edema, sleep apnea, or fertility concerns. Testosterone products carry warnings regarding blood pressure increases, hematocrit elevation, venous thromboembolism, worsening BPH symptoms, and potential adverse effects on spermatogenesis. Anabolic-androgenic steroid misuse is also associated with cardiovascular, endocrine, reproductive, and psychiatric harm. This product must not be used during pregnancy.

Side Effects

Possible adverse effects may include acne, oily skin, hair loss, mood changes, irritability, increased blood pressure, erythrocytosis/polycythemia, edema, gynecomastia, adverse lipid changes, suppression of spermatogenesis, infertility, and worsening urinary/prostate symptoms. Serious risks reported with testosterone products and anabolic-androgenic steroid misuse include venous thromboembolism, cardiovascular events, hepatic adverse effects, and neuropsychiatric complications.

Storage

Store according to the manufacturer’s labeled instructions. For testosterone enanthate injections, a common reference standard is controlled room temperature (20–25°C / 68–77°F); some formulations also specify room-temperature storage and avoidance of refrigeration or freezing. Protect from excessive temperature variation, and inspect the solution before administration.